Literature DB >> 2107667

Selective osteal salpingography and transvaginal catheter dilatation in the diagnosis and treatment of fallopian tube obstruction.

E K Lang1, H E Dunaway, W E Roniger.   

Abstract

Selective salpingography and transvaginal catheter dilatation were performed in 157 women with infertility to diagnose, localize, and classify obstructive diseases of the fallopian tubes and to correct obstruction of the proximal (uterine-end) tube. In 61 (39%) of the patients, the selective salpingograms showed patent tubes despite the fact that two previous hysterosalpingograms showed obstruction of the proximal (uterine-end) tube. Transvaginal catheter dilatation successfully recanalized the proximal portion of the tubes in 79 (82%) of 96 patients with obstructed tubes. In 18 of 25 with successful transvaginal catheter dilatation and 6-month follow-up salpingography, the tubes remained patent. Coexisting disease of the distal (ovarian-end) tubes was diagnosed in 29 (18%) of the patients. Pregnancy was achieved in 11 of the 157 patients (six in whom obstructions were corrected by transvaginal catheter dilatation and five in whom selective salpingograms showed patent tubes). There were no complications due to the procedure. The excellent diagnostic and therapeutic yield, lack of complications, and low cost justify the use of these percutaneous techniques to investigate female infertility and to treat obstruction of the uterine end of the fallopian tube.

Entities:  

Mesh:

Year:  1990        PMID: 2107667     DOI: 10.2214/ajr.154.4.2107667

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  2 in total

1.  Selective fallopian tube catheterisation in female infertility: clinical results and absorbed radiation dose.

Authors:  K Nakamura; T Ishiguchi; H Maekoshi; Y Ando; M Tsuzaka; T Tamiya; N Suganuma; T Ishigaki
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 2.  Interventional radiology. Application to family practice.

Authors:  M Asch; P K Law; N Jaffer
Journal:  Can Fam Physician       Date:  1996-08       Impact factor: 3.275

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.